BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help
Search Results
Documents 1-2 out of 2 found
  Current Search:  melas: 2     
HTML
100%
Penwest initiates second Phase IIa Melas syndrome trial
(Datamonitor via COMTEX) Penwest Pharmaceuticals, a drug development company, has initiated a Phase IIa clinical trial for A0001 in patients with the A3243G mitochondrial DNA point mutation and evidence of impaired mitochondrial function.

This point mutation...

Pharmacy Choice:  Feb 11 2010 10:21PM
Matching: melas 		Find similar documents
HTML
100%
Penwest Initiates Second Phase IIa Clinical Trial for A0001
PATTERSON, N.Y., Feb.

9, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co.

today announced that it has initiated a Phase IIa clinical trial for A0001 in patients with the A3243G mitochondrial DNA point mutation and evidence of impaired mitochondrial...

Interest!ALERT:  Feb 9 2010 5:30PM
Matching: melas 		Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.